Nanobiotix S.A. (EPA: NANO)
France
· Delayed Price · Currency is EUR
3.202
-0.100 (-3.03%)
Dec 20, 2024, 5:35 PM CET
Nanobiotix Revenue
Nanobiotix had revenue of 9.29M EUR in the half year ending June 30, 2024, with 598.95% growth. This brings the company's revenue in the last twelve months to 42.20M, up 526.17% year-over-year. In the year 2023, Nanobiotix had annual revenue of 36.21M with 658.12% growth.
Revenue (ttm)
42.20M
Revenue Growth
+526.17%
P/S Ratio
3.26
Revenue / Employee
383.67K
Employees
102
Market Cap
151.79M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech S.A. | 2.74B |
bioMérieux S.A. | 3.81B |
Eurofins Scientific SE | 6.72B |
Ipsen S.A. | 3.44B |
Virbac SA | 1.34B |
Ramsay Générale de Santé SA | 5.01B |
Nanobiotix News
- 4 days ago - NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024 - GlobeNewsWire
- 12 days ago - NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer - GlobeNewsWire
- 5 weeks ago - Nanobiotix gives Q3 update - Seeking Alpha
- 5 weeks ago - NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms - GlobeNewsWire
- 7 weeks ago - NANOBIOTIX to Participate in Multiple Investor Conferences in November - GlobeNewsWire
- 3 months ago - Nanobiotix reports 1H results - Seeking Alpha
- 3 months ago - NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth - GlobeNewsWire